Chapter 8 - Nanobiomaterials for medical devices and implants

Abstract

The global market of medical devices and implants is expected to grow to more than $110 billion by 2022. Nanobiomaterials have the potential to increase the biocompatibility of implants by modifying surface characteristics. They are also considered a promising approach for the prevention and treatment of implant-associated infection. There is a wide range of nanobiomaterials used for the manufacturing of these devices such as metals, polymers, composites, bio-ceramics, carbon-based materials, etc. The manufacturing of a nanobiomaterial-based device is an interdisciplinary approach, and novel fabrication technologies, such as additive manufacturing, are being employed for the development of such devices. Biosafety measures are of critical importance in the development of such products and nanobiomaterials presenting new challenges in terms of fabrication, biosafety, and large-scale production. Nevertheless, nanobiomaterial-based medical devices and implants can provide an excellent opportunity to invent novel biomedical products that can augment the performance and success rate of the device.